低剂量普得尼松和怀孕延长在威胁过早分娩一个随机试点研究
Nikolina Penava1,2, Ana Ćuk3, Dejan Tirić1,2
1Department of Obstetrics and Gynaecology, Clinical Hospital Center Mostar, Mostar, Bosnia and Herzegovina.
Journal of perinatal medicine
|July 25, 2025
概括
低剂量的普雷尼松可能会延长孕期的妇女与威胁过早分娩 (PTB) 和完整的膜. 这项试点研究发现,与标准护理相比,使用普德尼松的妊娠时间更长,没有观察到不良新生儿结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 新生儿科学 新生儿科学
背景情况:
- 过早分娩 (PTB) 仍然是新生儿发病率和死亡率的主要原因.
- 威胁到带有完整膜的PTB的标准管理包括毒解和呼吸应急综合征 (RDS) 预防.
- 在这种特定情况下,皮质类固醇如普得尼松在延长怀孕中的作用需要进一步研究.
研究的目的:
- 为了比较孕期延长和新生儿后果在妇女有威胁PTB和完整的膜治疗低剂量普雷尼松对比标准的协议.
- 评估低剂量普得尼松在延长妊娠时间方面的疗效.
- 评估与新生儿并发症有关的普得尼松的安全性.
主要方法:
- 一项试点随机对照试验,涉及26名怀孕24至34周之间有威胁PTB的妇女.
- 干预组连续接受低剂量普得尼松3周,并按照标准方案进行治疗.
- 对照组接受了威胁PTB的标准治疗;主要结果是妊娠时间,次要结果包括新生儿并发症 (RDS,IVH,NEC,通风,死亡率).
主要成果:
- 与对照组 (40.54天;p=0.001) 相比,干预组的妊娠延长时间 (65.38天) 显着更长.
- 妊娠年龄在分娩时大约是10天的时间在普得尼松组 (38.35周) 与对照组 (36.89周) 相比,虽然不是统计学上显著的 (p=0.153).
- 两组之间在新生儿结局上没有发现显著差异.
结论:
- 这项试点研究表明,低剂量的普雷尼松可以延长孕期的妇女,有威胁的早产和完整的膜,而不会增加不良的新生儿后果.
- 这些发现表明,在延长孕期方面,普德尼松有潜在的益处.
- 为了证实这些初步结果,需要进行更大的,充足的动力试验,因为该研究的样本大小小小,单中心设计.
相关概念视频
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Adrenergic Antagonists: ɑ and β-Receptor Blockers
611
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
611
Regression Toward the Mean
6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36


